Literature DB >> 3320376

Subcellular effects of adriamycin in the heart: a concise review.

P K Singal1, C M Deally, L E Weinberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3320376     DOI： 10.1016/s0022-2828(87)80392-9

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN： 0022-2828            Impact factor:   5.000


× No keyword cloud information.
  88 in total

1.  Intracellular distribution of peroxynitrite during doxorubicin cardiomyopathy: evidence for selective impairment of myofibrillar creatine kinase.

Authors:  Michael J Mihm; Fushun Yu; David M Weinstein; Peter J Reiser; John Anthony Bauer
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

Review 2.  Doxorubicin effects on contractile structures and molecules.

Authors:  R Colombo; A Milzani; A Necco; G Vailati
Journal:  Cytotechnology       Date:  1990-01       Impact factor: 2.058

3.  A digitized-fluorescence-imaging study of mitochondrial Ca2+ increase by doxorubicin in cardiac myocytes.

Authors:  E Chacon; R Ulrich; D Acosta
Journal:  Biochem J       Date:  1992-02-01       Impact factor: 3.857

4.  Significance of adaptation mechanisms in adriamycin induced congestive heart failure.

Authors:  P K Singal; N Siveski-Iliskovic; N Kaul; M Sahai
Journal:  Basic Res Cardiol       Date:  1992 Nov-Dec       Impact factor: 17.165

5.  Extracellular matrix alterations in cardiomyopathy: The possible crucial role in the dilative form.

Authors:  V I Kapelko
Journal:  Exp Clin Cardiol       Date:  2001

6.  Molecular mechanisms of heart muscle disease.

Authors:  W Lewis; T Papoian
Journal:  West J Med       Date:  1991-01

Review 7.  Doxorubicin-induced apoptosis: implications in cardiotoxicity.

Authors:  B Kalyanaraman; Joy Joseph; Shashi Kalivendi; Suwei Wang; Eugene Konorev; Srigiridhar Kotamraju
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

Review 8.  Cardio-Oncology: A Focused Review of Anthracycline-, Human Epidermal Growth Factor Receptor 2 Inhibitor-, and Radiation-Induced Cardiotoxicity and Management.

Authors:  Jean Domercant; Nichole Polin; Eiman Jahangir
Journal:  Ochsner J       Date:  2016

9.  Copper deficient rat heart can compensate for doxorubicin-induced oxidant stress.

Authors:  J G Fischer; R L Tackett; E W Howerth; M A Johnson
Journal:  Biol Trace Elem Res       Date:  1993 May-Jun       Impact factor: 3.738

10.  Bicontinuous cubic liquid crystalline nanoparticles for oral delivery of Doxorubicin: implications on bioavailability, therapeutic efficacy, and cardiotoxicity.

Authors:  Nitin K Swarnakar; Kaushik Thanki; Sanyog Jain
Journal:  Pharm Res       Date:  2013-11-12       Impact factor: 4.200
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.